Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Irish Eyes May Smile On Taxes, But Medtronic Says There’s More To Covidien Deal

This article was originally published in The Gray Sheet

Executive Summary

The $42.9 billion Medtronic-Covidien deal is the largest pure medical device deal ever. It would move Medtronic’s corporate address to Ireland, with a lower tax rate, but executives emphasize negotiating power with hospitals, product synergies and emerging-market footprint, as well as new flexibility to use overseas cash, as core rationales for the deal.


Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts